Cancers ordered by how many products with status approved list them. Top 50 of 256 cancers with a value; ties are broken by name. 435 of 443 approved products name at least one cancer (98%).
206 more cancers have a value below the top 50; the full list of cancers is at /cancers/.
Counts drug records with status approved and at least one approval record whose cancers field lists the cancer. A product approved in several cancers counts once for each. The context column counts trial records naming the cancer. Supportive care medicines (antiemetics, growth factors, epoetins, bone-modifying agents, antidotes, opioids for cancer pain, immunoglobulin; drug records flagged supportive) are not products or treatments here and are left out.
Coverage. 435 of 443 approved products name at least one cancer (98%). Rows with a value of zero are not listed. Nothing is weighted, imputed or averaged; the ordering is by the number shown, then by name.
Machine-readable copy: /rankings/cancers-by-approved-drugs/data.json. Registry: src/lib/rankings.ts.